Enzyme modulators and treatments

• 收藏
• 分享

专利权人:

LLC;Deciphera Pharmaceuticals

发明人:

Petillo, Peter A.,Flynn, Daniel L.

申请号：

AU2005321946

公开号：

AU2005321946B2

申请日:

2005.12.23

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

Novel compounds and methods of using those compounds for the treatment of inflammatory conditions, hyperproliferative diseases, cancer, and diseases characterized by hypervascularization are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein ab1 kinase protein, bcr-ab1 kinase protein, braf kinase protein, VEGFR kinase protein, or PDGFR kinase protein comprises the step of contacting said kinase protein with the novel compounds.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/